Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 931-297-3 | CAS number: -
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Effect on fertility: via oral route
- Endpoint conclusion:
- no study available
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no adverse effect observed
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
For assessment of reproductive toxicity/fertility a read across to HDI oligomers, isocyanurate type (EC 931 -274 -8) is applied. This substance is a close structural analogue to HDI oligomers, iminooxadiazindione type, also derived from catalytic oligomerisation of 1,6 -hexamethylene diisocyanate (HDI; CAS 822 -06 -0) and also belonging to the CAS number 28182-81-2 (Hexane, 1,6 - diisocyanato-, homopolymer).The read across is based on physicochemical and toxicological similarity. In fact, comparison of the toxicological endpoints, that are available for both of the two substances reveal good correlation.
| Toxicological endpoint | HDI oligomers, isocyanurate type | HDI oligomers, iminooxadiazindione type |
| Acute oral toxicity | > 2000 mg/kg | > 2000 mg/kg |
| Acute inhalation toxicity (pulmonary irritant study) | NOAEL 3 mg/m³ | NOAEL 2.1 mg/m³ |
| Skin Irritation/Corrosion | slight irritation/no classification required | slight irritation/no classification required |
| Eye Irritation/Corrosion | very slight irritation/no classification required | very slight irritation/no classification required |
| Skin Sensitisation | classification required | classification required |
| Bacterial Mutagenicity (Ames) | negative | negative |
With respect to Inhalation Toxicity an expert statement is available justifying the read across (Pauluhn, Comparison of pulmonary irritation potency..., Bayer HealthCare AG, 2008; attached to this endpoint summary).
Therefore, test results obtained for HDI oligomers, isocyanurate type can be transferred to HDI oligomers, iminooxadiazindione type and data on reproductive toxicity/fertility of HDI oligomers, isocyanurate type are also valid for HDI oligomers, iminooxadiazindione type. This approach is in accordance with Annex XI, section 1.5 of the REACH Regulation (Regulation (EC) No 1907/2006).
Based on the read across to HDI oligomers, isocyanurate type a data waiving is claimed for toxicity to reproduction for HDI oligomers, iminooxadiazindione type. The rationale for waiving additional animal studies on reproductive toxicity for aliphatic diisocyanate monomers and their polyisocyanates is attached to this endpoint summary.
Justification for selection of Effect on fertility via inhalation route:
No definite reproductive toxicity study is available for the substance. Based on read-across two reproductive toxicity screenings are available, but none is selected here, since both are considered relevant for assessment.
Effects on developmental toxicity
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no adverse effect observed
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Additional information
For assessment of developmental toxicity a read across to HDI oligomers, isocyanurate type (EC 931 -274 -8) is applied. This substance is a close structural analogue to HDI oligomers, iminooxadiazindione type, also derived from catalytic oligomerisation of 1,6 -hexamethylene diisocyanate (HDI; CAS 822 -06 -0) and also belonging to the CAS number 28182-81-2 (Hexane, 1,6 - diisocyanato-, homopolymer). The read across is based on physicochemical and toxicological similarity. In fact, comparison of the toxicological endpoints, that are available for both of the two substances reveal good correlation.
| Toxicological endpoint | HDI oligomers, isocyanurate type | HDI oligomers, iminooxadiazindione type |
| Acute oral toxicity | > 2000 mg/kg | > 2000 mg/kg |
| Acute inhalation toxicity (pulmonary irritant study) | NOAEL 3 mg/m³ | NOAEL 2.1 mg/m³ |
| Skin Irritation/Corrosion | slight irritation/no classification required | slight irritation/no classification required |
| Eye Irritation/Corrosion | very slight irritation/no classification required | very slight irritation/no classification required |
| Skin Sensitisation | classification required | classification required |
| Bacterial Mutagenicity (Ames) | negative | negative |
With respect to Inhalation Toxicity an expert statement is available justifying the read across (Pauluhn, Comparison of pulmonary irritation potency..., Bayer HealthCare AG, 2008; attached to this endpoint summary).
Therefore, test results obtained for HDI oligomers, isocyanurate type can be transferred to HDI oligomers, iminooxadiazindione type and data on developmental toxicity of HDI oligomers, isocyanurate type are also valid for HDI oligomers, iminooxadiazindione type. This approach is in accordance with Annex XI, section 1.5 of the REACH Regulation (Regulation (EC) No 1907/2006).
Based on the read across to HDI oligomers, isocyanurate type a data waiving is claimed for developmental toxicity for HDI oligomers, iminooxadiazindione type. The rationale for waiving additional animal studies on reproductive toxicity for aliphatic diisocyanate monomers and their polyisocyanates is attached to this endpoint summary.
Justification for selection of Effect on developmental toxicity: via oral route:
Inhalation is the relevant route of exposure during use.
Justification for selection of Effect on developmental toxicity: via inhalation route:
No study is selected, since three fully reliable developmental toxicity studies are available based on read across, and are all considered relevant for assessment.
Justification for selection of Effect on developmental toxicity: via dermal route:
Inhalation is the relevant route of exposure during use.
Justification for classification or non-classification
According to Regulation (EC) No 1272/2008, Annex I, no classification is warranted for toxicity to reproduction.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
